These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1416323)

  • 1. Lithium absorption prevented by sodium polystyrene sulfonate in volunteers.
    Tomaszewski C; Musso C; Pearson JR; Kulig K; Marx JA
    Ann Emerg Med; 1992 Nov; 21(11):1308-11. PubMed ID: 1416323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sodium polystyrene sulfonate on lithium bioavailability.
    Bélanger DR; Tierney MG; Dickinson G
    Ann Emerg Med; 1992 Nov; 21(11):1312-5. PubMed ID: 1416324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vivo binding of lithium using the cation exchange resin sodium polystyrene sulfonate.
    Gehrke JC; Watling SM; Gehrke CW; Zumwalt R
    Am J Emerg Med; 1996 Jan; 14(1):37-8. PubMed ID: 8630152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of the cation exchange resin, sodium polystyrene sulfonate, to decrease iron absorption.
    Shepherd G; Klein-Schwartz W; Burstein AH
    J Toxicol Clin Toxicol; 2000; 38(4):389-94. PubMed ID: 10930055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of sodium polystyrene sulfonate in a lithium overdose.
    Roberge RJ; Martin TG; Schneider SM
    Ann Emerg Med; 1993 Dec; 22(12):1911-5. PubMed ID: 8239115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro binding of lithium using the cation exchange resin sodium polystyrene sulfonate.
    Linakis JG; Savitt DL; Lockhart GR; Trainor B; Lacouture PG; Lewander WJ
    Am J Emerg Med; 1995 Nov; 13(6):669-70. PubMed ID: 7575808
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple-dose sodium polystyrene sulfonate in lithium intoxication: an animal model.
    Linakis JG; Eisenberg MS; Lacouture PG; Maher TJ; Lewander WJ; Driscoll JL; Woolf A
    Pharmacol Toxicol; 1992 Jan; 70(1):38-40. PubMed ID: 1594533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Pharmacodynamic Effects of the Potassium Binder RDX7675 in Mice.
    Davidson JP; King AJ; Kumaraswamy P; Caldwell JS; Korner P; Blanks RC; Jacobs JW
    J Cardiovasc Pharmacol Ther; 2018 May; 23(3):244-253. PubMed ID: 29130735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods used to decrease lithium absorption or enhance elimination.
    Scharman EJ
    J Toxicol Clin Toxicol; 1997; 35(6):601-8. PubMed ID: 9365427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro binding of lithium using the cation exchange resin sodium polystyrene sulfonate.
    Watling SM; Gehrke JC; Gehrke CW; Zumwalt R; Pribble J
    Am J Emerg Med; 1995 May; 13(3):294-6. PubMed ID: 7755820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro binding of iron with the cation-exchange resin sodium polystyrene sulfonate.
    O'Connor TA; Gruner BA; Gehrke JC; Watling SM; Gehrke CW
    Ann Emerg Med; 1996 Nov; 28(5):504-7. PubMed ID: 8909271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of sodium polystyrene sulfonate for reduction of plasma lithium concentrations after chronic lithium dosing in mice.
    Linakis JG; Savitt DL; Wu TY; Lockhart GR; Lacouture PG
    J Toxicol Clin Toxicol; 1998; 36(4):309-13. PubMed ID: 9711196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium polystyrene sulfonate: a cation exchange resin used in treating hyperkalemia.
    Meyer I
    ANNA J; 1993 Feb; 20(1):93-5. PubMed ID: 8431031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium polystyrene sulfonate used to reduce the potassium content of a high-protein enteral formula: a quantitative analysis.
    Rivard AL; Raup SM; Beilman GJ
    JPEN J Parenter Enteral Nutr; 2004; 28(2):76-8. PubMed ID: 15080600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtherapeutic serum quetiapine concentrations after absorption inhibition by binding resins: a case report.
    Hoge RH; Arbouw ME; Radstake SD; van Berlo-van de Laar IR
    J Clin Pharm Ther; 2015 Jun; 40(3):355-7. PubMed ID: 25808008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD.
    Lepage L; Dufour AC; Doiron J; Handfield K; Desforges K; Bell R; Vallée M; Savoie M; Perreault S; Laurin LP; Pichette V; Lafrance JP
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2136-42. PubMed ID: 26576619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rectally administered sodium polystyrene sulfonate.
    Gales MA; Gales BJ; Dyer ME; Orr SR
    Am J Health Syst Pharm; 1995 Dec; 52(24):2813-5. PubMed ID: 8748567
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age.
    Noel JA; Bota SE; Petrcich W; Garg AX; Carrero JJ; Harel Z; Tangri N; Clark EG; Komenda P; Sood MM
    JAMA Intern Med; 2019 Aug; 179(8):1025-1033. PubMed ID: 31180477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potassium repletion fails to interfere with reduction of serum lithium by sodium polystyrene sulfonate in mice.
    Linakis JG; Savitt DL; Trainor BJ; Young JE; Lacouture PG
    Acad Emerg Med; 2001 Oct; 8(10):956-60. PubMed ID: 11581080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium polystyrene sulfonate for the treatment of acute hyperkalemia: a retrospective study.
    Hagan AE; Farrington CA; Wall GC; Belz MM
    Clin Nephrol; 2016 Jan; 85(1):38-43. PubMed ID: 26587776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.